Here are three notes:
1. The shares were sold at $38.28 per share for a total value of $62.43 million.
2. Conmed’s 52-week high is $60.662 and the 52-week low is $35.51.
3. The company has a market cap of $1.03 billion.
More articles on devices:
Materialise, Mathys pen agreement — 4 highlights
Amedica to present clinical trial for CASCADE — 5 notes
Arthrex named one of Fortune’s 15 best workplaces for production: 4 things to know
